September 20, 2022
Earl and I begin this journey with some hope that we can find a way to control the effects of his NASH, which is a liver disease which we believe was caused by a childhood case of hepatitis.
This is an acronym for non alcoholic steatotic hepatitis which is a chronic inflammation of the liver. He is at stage 4. Next would be liver failure.
We entered the world of clinical trial with a visit to the Sierra Clinic.
From this visit we were sent to various diagnostic appointments to assess his acceptance into the study. first was an ultrasound then a liver biopsy on October 18.
Earl passed all the criteria and was accepted into the program in November 2022.
Comments
Post a Comment